Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Impact of the COVID Pandemic on Corruption Risk Models
Top 10 International Anti-Corruption Developments for December 2021
Neither Swift Nor Sequoia – First Circuit Charts Own Path on DOJ Veto Authority; U.S. and California ex rel. John R. Borzilleri M.D. v Bayer Healthcare Pharmaceuticals Inc., United States Court of Appeals for the First Circuit No. 20-1066
OIG Joint Venture Advisory Opinion Does Not Consider Multiple Court Decisions That Undermine the Conclusions in its Opinion
Assessing and Managing Third Party Sanctions Risks
The “S” Learning Curve for Compliance
Four Alaskans Sentenced for Bribery and Fraud in SDVOSB Snow Removal Contracting
Lab Owner Pleads Guilty to $6.9 Million Medicare Fraud Scheme Involving Kickbacks and Bribery
Federal Contractor Threatened With Suspension and Debarment for Not Submitting Affirmative Action Plans
SDVOSB Loses Verification Status Due to False Claims Act Allegations
Will FDA and DOJ Reassert Their Enforcement Muscle With Life Sciences in 2022?
Industries Face Growing Cybersecurity, Compliance Risks
Culture Transformation
Louisiana Woman Sentenced in Pharmaceutical Kickback Payment Fraud
Diversity, Inclusion & Equity Training for Boards – Not Just a Compliance Exercise
How to Conduct Compliance and ESG Diligence in M&A
“Person” of the Year: Environmental, Social, and Governance
2022 Federal Compliance Enforcement Outlook
Doctor Pays $228,000 After Allegedly Billing for Drug Tests He Could Not Perform
Keep reading
